FDA Inspection 580653 — Minnesota Molecular And Cellular Therapeutics Facility
The FDA completed an inspection of Minnesota Molecular And Cellular Therapeutics Facility on Apr 17, 2009 in Saint Paul, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 17, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional Details
Sponsor, Contract Research Organization